Holen Sie sich die Stockscreener-App
0.842
2.67%
0.0219
Handel nachbörslich:
.86
0.018
+2.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTXR?
Forum
Prognose
Aktiensplit
Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.44%
10.97
|
9.3408 | 10.12 | 8.6721 | 10.69 |
| Operating Income/Loss |
17.44%
-10.97
|
-9.3408 | -10.12 | -8.6721 | -10.69 |
| Nonoperating Income/Loss |
913.27%
2.57
|
0.2536 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
7.56%
-8.4002
|
-9.0872 | -9.7999 | -8.3353 | -10.38 |
| Income Tax Expense/Benefit, Deferred |
0.00%
0.144
|
0.144 | 0.144 | 0.144 | 0.144 |
| Income Tax Expense/Benefit |
0.00%
0.144
|
0.144 | 0.144 | 0.144 | 0.144 |
| Income/Loss From Continuing Operations After Tax |
7.44%
-8.5442
|
-9.2312 | -9.9439 | -8.4793 | -10.53 |
|
Net Income/Loss
|
7.44%
-8.5442
|
-9.2312 | -9.9439 | -8.4793 | -10.53 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | 1.1512 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.07%
159.07
|
158.96 | 2.5487 | 153.78 | 146.25 |
| Diluted Average Shares |
0.07%
159.07
|
158.96 | 2.5487 | 153.78 | 146.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | 1.1512 | - | - |
0.69%
21.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):